Resmed – First Linde Then CNBC And Jim Cramer
You will recall two days ago the market noise that Resmed was about to be picked up by German Linde. We blogged about it here.
Now CNBC’s Jim Cramer talked about them benefiting from the potential reversal or low impact of competitive bidding. (I don’t think competitive bidding will be substantially reversed just to be clear.
Jim Cramer goes on to issue a potential target price of $53 which is a cool 30% premium.
Related posts:
- (Happy?) Birthday National Competitive Bidding – Medicare – Homecare
- The New York Times Slams Congress On Medicare And National Competitive Bidding Delays -Names Industry Players
- Would a Linde Acquisition Of Resmed Make Sense?
- George Bush Veto Of National Competitive Bidding Overturned By Congress and The Senate
- Why Invest In Homecare? – Revisited – Blackstone Bids For Apria
0 comments
Kick things off by filling out the form below.
Leave a Comment